ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement (NCT03973372)
Advancing Liver Therapeutic Approaches (ALTA). The ALTA Consortium Study Group for the Management of Portal Hypertension - A 5-year Longitudinal Observational Study of Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) Placement
🩺 Plain-English Summary (8th-Grade Level)
ALTA is a multicenter consortium focused on the management of portal hypertension. ALTA TIPS is a longitudinal observational study of patients who are undergoing transjugular intrahepatic portosystemic shunt (TIPS) placement. ALTA will create a database that will provide clinical parameters and outcomes of patients undergoing TIPS as part of their standard of care in hopes of answering key clinical questions.
Who can join: Review the eligibility criteria below.
Location: University of Arizona — Phoenix, Arizona
Age range: 18 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (14 Sites)
- University of Arizona — Phoenix, Arizona
- Stanford — Redwood City, California
- Scripps Health — San Diego, California
- University of California San Francisco — San Francisco, California
- University of Florida — Gainesville, Florida
- Northwestern — Chicago, Illinois
- University of Chicago — Chicago, Illinois
- University of Minnesota — Minneapolis, Minnesota
- Mayo Clinic Rochester — Rochester, Minnesota
- Columbia University — New York, New York
- Weill Cornell — New York, New York
- Baylor Scott & White Liver Consultants of Texas — Dallas, Texas
- University of Texas Southwestern Medical Center — Dallas, Texas
- University of Wisconsin Madison — Madison, Wisconsin
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cirrhosis, Liver
- LiveSMART Trial to Prevent Falls in Patients With Cirrhosis - Supplementary Study — Ann Arbor, Michigan
- Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease — Ann Arbor, Michigan
- Angiotensin 2 for AKI After OLT — Los Angeles, California
- Erlotinib for Hepatocellular Carcinoma Chemoprevention — Dallas, Texas
- Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics — Chandler, Arizona
Explore by condition: All Cirrhosis, Liver clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.